| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.70B | 4.70B | 4.17B | 4.28B | 4.20B | 3.41B |
| Gross Profit | 2.46B | 2.46B | 2.41B | 2.06B | 1.81B | 1.70B |
| EBITDA | 2.38B | 2.38B | 2.10B | 1.74B | 1.49B | 1.38B |
| Net Income | 1.20B | 1.20B | 1.04B | 885.32M | 774.40M | 665.56M |
Balance Sheet | ||||||
| Total Assets | 28.91B | 28.91B | 25.19B | 22.52B | 22.19B | 19.61B |
| Cash, Cash Equivalents and Short-Term Investments | 203.80M | 203.80M | 307.34M | 15.40M | 51.55M | 116.72M |
| Total Debt | 9.30B | 9.30B | 8.13B | 7.12B | 8.37B | 7.56B |
| Total Liabilities | 15.35B | 15.35B | 13.04B | 11.65B | 12.77B | 11.70B |
| Stockholders Equity | 13.56B | 13.56B | 12.16B | 10.87B | 9.42B | 7.91B |
Cash Flow | ||||||
| Free Cash Flow | -1.51B | -1.51B | -1.20B | 653.77M | -1.47B | -3.05B |
| Operating Cash Flow | 2.05B | 2.05B | 1.73B | 3.46B | 977.58M | -1.08B |
| Investing Cash Flow | -3.56B | -3.56B | -2.92B | -2.80B | -2.43B | -1.96B |
| Financing Cash Flow | 1.41B | 1.41B | 1.48B | -696.77M | 1.39B | 3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $5.86B | 12.64 | 5.42% | 3.07% | -23.15% | 157.45% | |
70 Outperform | $7.96B | 11.98 | 14.87% | 3.92% | 1.10% | 140.04% | |
68 Neutral | $4.62B | 17.95 | 8.51% | 3.45% | 15.06% | 12.27% | |
66 Neutral | $26.98B | 22.35 | 9.32% | 2.15% | 12.91% | 9.86% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | $4.68B | 13.95 | 14.62% | 4.01% | 13.94% | 13.93% | |
64 Neutral | $20.06B | 22.20 | 10.23% | 2.69% | 19.62% | 12.87% |